Sugi Predict

Sugi Predict / Targets / LARP1

LARP1

La-related protein 1 · Q6PKG0 · LARP1 on Sugi Atlas →

0 patent compounds predicted against LARP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LARP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis PHASE3COMPLETED
Lamivudine as a Novel Clinical Effort for Rett Syndrome PHASE2ENROLLING_BY_INVITATION
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy EARLY_PHASE1RECRUITING
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Genetics of Familial and Sporadic ALS nanCOMPLETED
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies nanUNKNOWN
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Evaluate the Effort Test as a Therapeutic Monitoring Tool in Acute Rhabdomyolyses nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Characteristics of Idiopathic Familial Voice Disorders nanCOMPLETED
Collection of Blood Samples for DNA in Motor Neuron Disease nanCOMPLETED
Role of SLURP-1 in Melanoma and Melanoma Stem Cells nanUNKNOWN
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients nanACTIVE_NOT_RECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis nanCOMPLETED
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype nanCOMPLETED
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Genetic Study of Amyotrophic Lateral Sclerosis in Norway nanRECRUITING
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis nanUNKNOWN
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate nanRECRUITING
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a LARP1 binder may also engage these)

ProteinNameSimilarity
Q659C4 — 1.000 Q659C4 →
Q6ZQ58 — 0.997 Q6ZQ58 →
Q5RAK6 — 0.995 Q5RAK6 →
Q940X9 — 0.994 Q940X9 →
A0A0R4IZ84 — 0.993 A0A0R4IZ84 →
Q8K0V4 — 0.993 Q8K0V4 →
Q90YL3 — 0.993 Q90YL3 →
Q6DD45 — 0.993 Q6DD45 →
Q9H329 — 0.992 Q9H329 →
P35611 — 0.992 P35611 →
Q6NZJ6 — 0.992 Q6NZJ6 →
P84903 — 0.992 P84903 →
Q7TN02 — 0.992 Q7TN02 →
STIM1 Stromal interaction molecule 1 0.992 landscape →
Q5HZJ0 — 0.992 Q5HZJ0 →
Q8BG95 — 0.992 Q8BG95 →
Q6GLQ4 — 0.992 Q6GLQ4 →
Q5PQK8 — 0.992 Q5PQK8 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.991 landscape →
Q9NRR4 — 0.991 Q9NRR4 →
Q94AM9 — 0.991 Q94AM9 →
P0DJJ3 — 0.991 P0DJJ3 →
O60237 — 0.991 O60237 →
Q8BMD7 — 0.991 Q8BMD7 →
Q9R0A0 — 0.991 Q9R0A0 →
Q8BHX3 — 0.991 Q8BHX3 →
Q8IZ21 — 0.991 Q8IZ21 →
Q9DDT2 — 0.990 Q9DDT2 →
Q5RDL3 — 0.990 Q5RDL3 →
BRPF3 Bromodomain and PHD finger-containing protein 3 0.990 landscape →